0
0
Home » Medical Devices » In Vitro Diagnostics

ALK Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

The ALK tests market size was valued at $58.6 million in 2021. The ALK tests market research report is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on ALK Tests market for the year 2020 and beyond. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women.

ALK Tests Market Size For more insights, download a free report sample

Which are the key regions in the ALK tests market?

The key regions in the ALK tests market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.

Which are the key countries in the ALK tests market?

The key countries in the ALK tests market are Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US.

Which are the key segments in the ALK tests market?

The key segments in the ALK tests market are ALK Immunohistochemistry (IHC) Tests, ALK In Situ Hybridization (ISH) Tests, ALK Next Generation Sequencing (NGS) Tests, and ALK Nucleic Acid Amplification Tests (NAATs). ALK In Situ Hybridization (ISH) Tests has the highest market share in the ALK tests market.

ALK tests market, by segments

ALK tests market, by segmentsFor more segment insights, download a free report sample

Which are the key companies in the ALK tests market?

The key companies in the ALK tests market are F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Danaher Corp, Biocare Medical LLC, Thermo Fisher Scientific Inc, Cancer Diagnostics, Inc., Abbott Laboratories, Merck KGaA, Sysmex Corp, ZytoVision GmbH, Qiagen NV, Bio-Rad Laboratories Inc, Takara Bio Inc, Integrated DNA Technologies Inc.

ALK tests market, by companies

ALK tests market, by companiesFor more company insights, download a free report sample

Market report overview

Market size 2021 $58.6 million
Key regions North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa
Key countries Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US
Key segments ALK Immunohistochemistry (IHC) Tests, ALK In Situ Hybridization (ISH) Tests, ALK Next Generation Sequencing (NGS) Tests, and ALK Nucleic Acid Amplification Tests (NAATs)
Key companies F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Danaher Corp, Biocare Medical LLC, Thermo Fisher Scientific Inc, Cancer Diagnostics, Inc., Abbott Laboratories, Merck KGaA, Sysmex Corp, ZytoVision GmbH, Qiagen NV, Bio-Rad Laboratories Inc, Takara Bio Inc, Integrated DNA Technologies Inc

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the ALK Tests marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on ALK Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving ALK Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ALK Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific ALK Tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Players

F. Hoffmann-La Roche Ltd

Agilent Technologies Inc

Danaher Corp

Biocare Medical LLC

Thermo Fisher Scientific Inc

Cancer Diagnostics, Inc.,

Abbott Laboratories

Merck KGaA

Sysmex Corp

ZytoVision GmbH

Qiagen NV

Bio-Rad Laboratories Inc

Takara Holdings Inc

Integrated DNA Technologies Inc

Illumina Inc

New England Biolabs Inc

EntroGen, Inc

Amoy Diagnostics Co Ltd

Panagene Inc

Frequently Asked Questions

The ALK tests market was valued at $58.6 million in the year 2021.

 

 

 

 

The key regions in the ALK tests market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.

The key countries in the ALK tests market are Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US.

The key segments in the ALK tests market are ALK Immunohistochemistry (IHC) Tests, ALK In Situ Hybridization (ISH) Tests, ALK Next Generation Sequencing (NGS) Tests, and ALK Nucleic Acid Amplification Tests (NAATs).

The key companies in the ALK tests market are F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Danaher Corp, Biocare Medical LLC, Thermo Fisher Scientific Inc, Cancer Diagnostics, Inc., Abbott Laboratories, Merck KGaA, Sysmex Corp, ZytoVision GmbH, Qiagen NV, Bio-Rad Laboratories Inc, Takara Bio Inc, Integrated DNA Technologies Inc

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports